Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival (original) (raw)
Aebersold DM, Burri P, Beer KT, Laissue J, Djonov V, Greiner RH and Semenza GL (2001) Expression of hypoxia-inducible factor-1α: a novel predictive and prognostic parameter in the radiotherapy of orop haryngeal cancer. Cancer Res61: 2911–2916 CASPubMed Google Scholar
Birner P, Schindl M, Obermair A, Plank C, Breitenecker G and Oberhuber G (2000) Overexpression of hypoxia-inducible factor 1α is a marker for an unfavorable prognosis in early-stage invasive cervical cancer. Cancer Res60: 4693–4696 CASPubMed Google Scholar
Blancher C and Harris AL (1998) The molecular basis of the hypoxia response pathway: tumour hypoxia as a therapy target. Cancer Metast Rev17: 187–194 ArticleCAS Google Scholar
Bos R, Zhong H, Hanrahan CF, Mommers EC, Semenza GL, Pinedo HM, Abeloff MD, Simons JW, van Diest PJ and van der Wall E (2001) Levels of hypoxia-inducible factor-1α during breast carcinogenesis. J Natl Cancer Inst93: 309–314 ArticleCAS Google Scholar
Brekken RA, Huang X, King SW and Thorpe PE (1998) Vascular endothelial growth factor as a marker of tumor endothelium. Cancer Res58: 1952–1959 CASPubMed Google Scholar
Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D, Keshert E and Keshet E (1998) Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature394: 485–490 ArticleCAS Google Scholar
Chandel NS, McClintock DS, Feliciano CE, Wood TM, Melendez JA, Rodriguez AM and Schumacker PT (2000) Reactive oxygen species generated at mitochondrial complex II stabilize HIF-1α during hypoxia: a mechanism of O2 sensing. J Biol Chem, (May 31).
de-Porter CR, Eeckhout I, Schelfhout AM, Geerts ML and Roels HJ (1994) Keratinocyte induced chemotaxis in the pathogenesis of Paget’s disease of the breast. Histopathology24: 349–356 Article Google Scholar
Dong Z, Kumar R, Yang X and Fidler IJ (1997) Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell88: 801–810 ArticleCAS Google Scholar
Ebert BL, Gleadle JM, O’Rourke JF, Bartlett SM, Poulton J and Ratcliffe PJ (1996) Isoenzyme specific regulation of genes involved in energy metabolism by hypoxia: similarities with the regulation of erythropoietin. J Biochem313: 809–814 ArticleCAS Google Scholar
Ema M, Taya S, Yokotani N, Sogawa K, Matsuda Y and Fujii-Kuriyama Y (1997) A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1α regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci USA94: 4273–4278 ArticleCAS Google Scholar
Faller DV (1999) Endothelial cell responses to hypoxic stress. Clin Exp Pharmacol Physiol26: 74–84 ArticleCAS Google Scholar
Feldser D, Agani F, Iyer NV, Pak B, Ferreira G and Semenza GL (1999) Reciprocal positive regulation of hypoxia-inducible factor 1α and insulin-like growth factor 2. Cancer Res59: 3915–3918 CASPubMed Google Scholar
Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD and Semenza GL (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol16: 4604–4013 ArticleCAS Google Scholar
Gatenby RA, Kessler HB, Rosenblum JS, Coia LR, Moldofsky PJ, Hart WH and Broder GJ (1988) Oxygen distribution in squamous cell carcinoma metastases and its relationship in outcome of radiation therapy. Int J Rad Oncol Biol Phys14: 831–838 ArticleCAS Google Scholar
Giatromanolaki A, Koukourakis M, O’Byrne K, Kaklamanis L, Dicoglou C, Trichia E, Whitehouse R, Harris AL and Gatter KC (1996) Non small cell lung cancer: C-erbB-2 correlates with low angiogenesis and poor prognosis. Anticancer Res16: 3819–3825 CASPubMed Google Scholar
Giatromanolaki A, Koukourakis MI, Kakolyris S, Turley H, O’Byrne K, Scott PAE, Pezzella F, Georgoulias V, Harris AL and Gatter KC (1998) Vascular endothelial growth factor, wild-type p53 and angiogenesis in early operable non-small cell lung cancer. Clin Cancer Res4: 3017–3024 CASPubMed Google Scholar
Giatromanolaki A, Sivridis E, Koukourakis MI, Georgoulias V, Gatter KC and Harris AL (1999) Intratumoral angiogenesis: a new prognostic indicator for stage I endometrial adenocarcinomas?. Oncol Res11: 205–212 CASPubMed Google Scholar
Giatromanolaki A, Koukourakis MI, Sivridis E, O’Byrne K, Cox G, Thorpe PE, Gatter KC and Harris AL (2000) co-expression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggets co-activation of angiogenic and migratory pathways. Clin Cancer Res6: 1917–1921 CASPubMed Google Scholar
Goldberg MA, Dunning SP and Bunn HF (1998) Regulation of the erythropoietin gene: evidence that oxygen sensor is a heme protein. Science, 1412–1415
Gopfert T, Gess B, Eckardt KU and Kurtz A (1996) Hypoxia signalling in the control of erythropoietin gene expression in rat hepatocytes. J Cell Physiol168: 354–361 ArticleCAS Google Scholar
Griffiths L, Dachs GU, Bicknell R, Harris AL and Stratford IJ (1997) The influence of oxygen-tension and pH on the expression of platelet-derived endothelial cell growth factor thymidine phosphorylase in human breast-tumor cells grown in vitro and in vivo. Cancer Res57: 570–572 CASPubMed Google Scholar
Gu YZ, Moran SM, Hogenesch JB, Wartman L and Bradfield CA (1998) Molecular characterization and chromosomal localization of a third α-class hypoxia inducible factor subunit, HIF3alpha. Gene Expr7: 205–213 CASPubMed Google Scholar
Huang LE, Arany Z, Livingston DM and Bunn HF (1996) Activation of Hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its a subunit. J Biol Chem271: 32253–32259 ArticleCAS Google Scholar
Huang LE, Gu J, Scheau M and Bunn F (1998) Reulation of hypoxia-inducible factor 1α is mediated by an O2-dependent degradation domain via the ubiquitine-proteasome pathway. Proc Natl Acad Sci USA95: 7987–7992 ArticleCAS Google Scholar
Jiang BH, Agani F, Passaniti A and Semenza GL (1997) V-SRC induces expression of hypoxia inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase-1: involvement of HIF-1 in tumor progression. Cancer Res57: 5328–5335 CASPubMed Google Scholar
Koukourakis MI, Giatromanolaki A, O’Byrne K, Comley M, Whitehouse R, Talbot DC, Gatter KC and Harris AL (1997a) Platelet-derived endothelial cell growth factor expression correlates with tumor angiogenesis and prognosis in non-small cell lung cancer. Br J Cancer4: 477–481 Article Google Scholar
Koukourakis MI, Giatromanolaki A, O’Byrne K, Whitehouse R, Talbot DC, Gatter KC and Harris AL (1997b) Potential role of bcl-2 as a suppressor of tumour angiogenesis in non small cell lung cancer. Int J Cancer74: 565–570 ArticleCAS Google Scholar
Koukourakis M, Giatromanolaki A, Kakolyris S, O’Byrne K, Apostolikas T, Skarlatos J, Gatter KC and Harris AL (1998) Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non small cell lung cancer. Impact on neoangiogenesis and survival. British J Cancer77: 1696–1703 ArticleCAS Google Scholar
Koukourakis MI, Giatromanolaki A, O’Byrne KJ, Cox J, Krammer B, Gatter KC and Harris AL (2000a) bcl-2 and c-erbB-2 proteins are involved in the regulation of VEGF and of Thymidine phosphorylase angiogenic activity in non-small cell lung cancer. Clin Exp Metast17: 545–554 Article Google Scholar
Koukourakis MI, Giatromanolaki A, Thorpe PE, Brekken RA, Sivridis E, Kakolyris S, Georgoulias V, Gatter KC and Harris AL (2000b) Prognostic and pathologic comparison of VEGF/KDR activated microvessel density (aMVD) vs. CD31 standard MVD (sMVD) in non-small cell lung cancer. Cancer Res60: 3088–3095 CASPubMed Google Scholar
Maxwell PH, Dachs GU, Gleadle JM, Nicholls LG, Harris AL, Stratford IJ, Hankinson O, Pugh CW and Ratclife PJ (1997) Hypoxia-inducible factor 1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci USA94: 8104–8109 ArticleCAS Google Scholar
Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER and Ratcliffe PJ (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature399: 271–275 ArticleCAS Google Scholar
Mazure NM, Chen EY, Laderoute KR and Giaccia AJ (1999) Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Haras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood90: 3322–3331 Google Scholar
Norris ML and Millhorn DE (1995) Hypoxia-induced protein binding to O2-responsive sequences on the tyrosine hydroxylase gene. J Biol Chem270: 23774–23779 ArticleCAS Google Scholar
O’Toole EA, Marinkovich MP, Peavey CL, Amieva MR, Furthmayr H, Mustoe TA and Woodley DT (1997) Hypoxia increases human keratinocyte motility on connective tissue. J Clin Invest100: 2881–2891 Article Google Scholar
Palmer LA, Semenza GL, Stoler MH and Johns RA (1998) Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. Am J Physiol274: 212–219 Google Scholar
Semenza GL and Wang GL (1992) A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol12: 5447–5454 ArticleCAS Google Scholar
Semenza GL, Nejfelt MK, Chi SM and Antonarakis SE (1991) Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc Natl Acad Sci USA88: 5680–5684 ArticleCAS Google Scholar
Takagi H, King GL and Aiello LP (1998) Hypoxia upregulates glucose transport activity through an adenosine-mediated increase of GLUT1 expression in retinal capillary endothelial cells. Diabetes47: 1480–1488 ArticleCAS Google Scholar
Talks KL, Turley H, Gatter KC, Maxwell PH, Pugh CW, Ratcliffe PJ and Harris AL (2000) The expression and distribution of the hypoxia inducible factors HIF-1á and HIF-2a in normal human tissues, cancers and tumor associated macrophages. Am J Pathol157: 2411–2421 Article Google Scholar
Tian H, McKnight L and Russel DW (1997) Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev11: 72–82 ArticleCAS Google Scholar
Tungekar MF, Gatter KC, Dunnill MS and Mason DY (1991) Ki-67 immunostaining and survival in operable lung cancer. Histopathology19: 545–550 ArticleCAS Google Scholar
Volm M and Koomagi R (2001) Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer. Anticancer Res20: 1527–1533 Google Scholar
Wiesener MS, Turley H, Allen WE, Willam C, Eckardt KU, Talks KL, Wood SM, Gatter KC, Harris AL, Pugh CW, Ratcliffe PJ and Maxwell PH (1998) Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1α. Blood92: 2260–2268 CASPubMed Google Scholar
Zagzag D, Zhong H, Scalzitti JM, Laughner E, Simons JW and Semenza GI (2000) Expression of hypoxia-inducible factor 1alpha in brain tumours: association with angiogenesis, invasion, and progression. Cancer88: 2606–2628 ArticleCAS Google Scholar
Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL and Simons JW (1999) Overexpression of Hypoxia-inducible factor 1α in common human cancers and their metastases. Cancer Res59: 5830–5835 CAS Google Scholar
Zundel W, Schindler C, Haas-Kogan D, Koong A, Kaper F, Chen E, Gottschalk AR, Ryan HE, Johnson RS, Jefferson AB, Stokoe D and Giaccia AJ (2000) Loss of PTEN facilitates HIF-1-mediated gene expression. Genes Dev14: 391–396 CASPubMedPubMed Central Google Scholar